BR112014019504A2 - alérgenos da erva-dos-prados e métodos e usos para modulação de resposta imune - Google Patents
alérgenos da erva-dos-prados e métodos e usos para modulação de resposta imuneInfo
- Publication number
- BR112014019504A2 BR112014019504A2 BR112014019504A BR112014019504A BR112014019504A2 BR 112014019504 A2 BR112014019504 A2 BR 112014019504A2 BR 112014019504 A BR112014019504 A BR 112014019504A BR 112014019504 A BR112014019504 A BR 112014019504A BR 112014019504 A2 BR112014019504 A2 BR 112014019504A2
- Authority
- BR
- Brazil
- Prior art keywords
- grassland
- methods
- immune response
- allergens
- individual
- Prior art date
Links
- 239000013566 allergen Substances 0.000 title abstract 3
- 230000028993 immune response Effects 0.000 title abstract 3
- 208000026935 allergic disease Diseases 0.000 abstract 2
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 2
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 2
- 102000004169 proteins and genes Human genes 0.000 abstract 2
- 108090000623 proteins and genes Proteins 0.000 abstract 2
- 230000000172 allergic effect Effects 0.000 abstract 1
- 208000010668 atopic eczema Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 208000035475 disorder Diseases 0.000 abstract 1
- 230000006058 immune tolerance Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/35—Allergens
- A61K39/36—Allergens from pollen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/543—Mucosal route intranasal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Botany (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261596156P | 2012-02-07 | 2012-02-07 | |
| US201261734886P | 2012-12-07 | 2012-12-07 | |
| PCT/US2013/025213 WO2013119863A1 (en) | 2012-02-07 | 2013-02-07 | Timothy grass allergens and methods and uses for immune response modulation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112014019504A2 true BR112014019504A2 (pt) | 2017-06-27 |
Family
ID=48948025
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112014019504A BR112014019504A2 (pt) | 2012-02-07 | 2013-02-07 | alérgenos da erva-dos-prados e métodos e usos para modulação de resposta imune |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US10428124B2 (enExample) |
| EP (1) | EP2812026A4 (enExample) |
| JP (1) | JP2015513527A (enExample) |
| KR (1) | KR20140129124A (enExample) |
| CN (1) | CN104203277A (enExample) |
| AU (1) | AU2013216993C1 (enExample) |
| BR (1) | BR112014019504A2 (enExample) |
| CA (1) | CA2864084A1 (enExample) |
| EA (1) | EA201491481A1 (enExample) |
| HK (1) | HK1204929A1 (enExample) |
| IN (1) | IN2014MN01513A (enExample) |
| MX (1) | MX2014009285A (enExample) |
| WO (1) | WO2013119863A1 (enExample) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2015054217A2 (en) | 2013-10-07 | 2015-04-16 | La Jolla Institute For Allergy And Immunology | Methods and uses for reducing an allergic response in a subject |
| WO2015054231A1 (en) | 2013-10-07 | 2015-04-16 | La Jolla Institute For Allergy And Immunology | Methods and uses for identifying responders to allergy therapy |
| WO2015077442A2 (en) | 2013-11-20 | 2015-05-28 | La Jolla Institute For Allergy And Immunology | Grass pollen immunogens and methods and uses for immune response modulation |
| EA201691028A1 (ru) | 2013-11-20 | 2017-01-30 | Ла Хойя Инститьют Фор Эллерджи Энд Иммьюнолоджи | Пан-иммуногены пыльцы, способы и применение для модуляции иммунного ответа |
| CA2933552A1 (en) | 2013-12-23 | 2015-07-02 | Alk-Abello A/S | Peptide combinations and uses thereof in treating dust mite allergy |
| WO2015131053A1 (en) | 2014-02-28 | 2015-09-03 | Alk-Abelló A/S | Polypeptides derived from phl p and methods and uses thereof for immune response modulation |
| JP6423889B2 (ja) * | 2014-10-07 | 2018-11-14 | サイトリミック株式会社 | Ｈｓｐ７０由来のペプチド、これを用いた癌の治療又は予防のための医薬組成物、免疫誘導剤、及び抗原提示細胞の製造方法 |
| EP3269733B1 (en) | 2015-03-09 | 2020-06-17 | Cytlimic Inc. | Peptide derived from gpc3, pharmaceutical composition for treatment or prevention of cancer using same, immunity inducer, and method for producing antigen-presenting cells |
| US10842848B2 (en) | 2015-04-07 | 2020-11-24 | Cytlimic Inc. | Method for treating cancer by adminstering poly I:C and LAG-3-IgG fusion protein |
| KR102430856B1 (ko) * | 2016-05-03 | 2022-08-08 | 에스큐지 바이오테크놀로지스 컴퍼니 | 관용을 유도하는 생체분자의 세포내 전달 |
| EP3527216B1 (en) | 2016-10-11 | 2024-02-14 | NEC Corporation | A medicine comprising a toll-like receptor agonist, lag-3 protein, a hsp70-derived peptide and a gpc3-derived peptide |
| WO2018199341A1 (ja) * | 2017-04-28 | 2018-11-01 | 学校法人藤田学園 | アレルギーの抗原およびそのエピトープ |
| CN114729929B (zh) * | 2019-11-25 | 2025-10-28 | 加利福尼亚大学董事会 | 诊断和治疗自闭症的抗原神经元特异性烯醇化酶肽 |
| CN120349374B (zh) * | 2025-03-25 | 2025-10-10 | 长沙理工大学 | 一种米渣短肽及其在降尿酸中的应用 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7214786B2 (en) * | 2000-12-14 | 2007-05-08 | Kovalic David K | Nucleic acid molecules and other molecules associated with plants and uses thereof for plant improvement |
| AUPR775401A0 (en) * | 2001-09-18 | 2001-10-11 | Monash University | Novel Epitopes and Uses Thereof |
| ES2384045T3 (es) | 2002-06-25 | 2012-06-28 | Merck Patent Gmbh | Secuencia de ADN y preparación recombinante del alérgeno del polen de gramíneas PHI P 4 |
| AU2003251674B2 (en) * | 2002-08-19 | 2009-09-03 | Merck Patent Gmbh | Variants of the major allergen Phl p 1 from timothy grass |
| MXPA05005528A (es) | 2002-11-26 | 2006-04-05 | Alk Abello As | Producto farmaceutico de alergeno. |
| EP3059306A1 (en) * | 2005-01-12 | 2016-08-24 | Monsanto Technology LLC | Genes and uses for plant improvement |
| US20090070897A1 (en) * | 2006-01-12 | 2009-03-12 | Goldman Barry S | Genes and uses for plant improvement |
| ES2950396T3 (es) * | 2008-02-01 | 2023-10-09 | Prota Therapeutics Pty Ltd | Un método para inducir tolerancia a un alérgeno |
| EP2388268A1 (en) * | 2010-05-18 | 2011-11-23 | Stallergenes S.A. | Recombinant Der p 2 expressed in Pichia pastoris as a "natural-like" allergen for immunotherapy and diagnostic purposes |
| KR20130118884A (ko) | 2010-10-15 | 2013-10-30 | 알크-아벨로 에이/에스 | 알레르겐 소스 물질로부터 유도된 무관련 알레르겐을 이용한 과민성 면역반응의 억제 |
| US20120100163A1 (en) | 2010-10-15 | 2012-04-26 | Alk-Abello A/S | Suppression of a type 1 hypersensitivity immune response with an unrelated antigen |
| EP2831102A4 (en) | 2012-03-26 | 2015-12-02 | Pronutria Inc | NUTRITIONAL FRAGMENTS, PROTEINS THEREFOR AND METHOD |
| CA2870399A1 (en) | 2012-04-16 | 2013-10-24 | Alk-Abello A/S | Plant profilin polypeptides for use in non-specific allergy immunotherapy |
-
2013
- 2013-02-07 KR KR1020147025030A patent/KR20140129124A/ko not_active Withdrawn
- 2013-02-07 JP JP2014556692A patent/JP2015513527A/ja active Pending
- 2013-02-07 MX MX2014009285A patent/MX2014009285A/es unknown
- 2013-02-07 US US14/375,980 patent/US10428124B2/en active Active
- 2013-02-07 CA CA2864084A patent/CA2864084A1/en not_active Abandoned
- 2013-02-07 HK HK15105520.1A patent/HK1204929A1/xx unknown
- 2013-02-07 IN IN1513MUN2014 patent/IN2014MN01513A/en unknown
- 2013-02-07 BR BR112014019504A patent/BR112014019504A2/pt not_active IP Right Cessation
- 2013-02-07 AU AU2013216993A patent/AU2013216993C1/en not_active Ceased
- 2013-02-07 WO PCT/US2013/025213 patent/WO2013119863A1/en not_active Ceased
- 2013-02-07 EA EA201491481A patent/EA201491481A1/ru unknown
- 2013-02-07 EP EP13747032.4A patent/EP2812026A4/en not_active Withdrawn
- 2013-02-07 CN CN201380008385.XA patent/CN104203277A/zh active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CN104203277A (zh) | 2014-12-10 |
| CA2864084A1 (en) | 2013-08-15 |
| AU2013216993A1 (en) | 2014-08-21 |
| EA201491481A1 (ru) | 2014-11-28 |
| HK1204929A1 (en) | 2015-12-11 |
| MX2014009285A (es) | 2015-02-04 |
| EP2812026A1 (en) | 2014-12-17 |
| AU2013216993C1 (en) | 2017-01-19 |
| AU2013216993B2 (en) | 2016-09-15 |
| JP2015513527A (ja) | 2015-05-14 |
| US10428124B2 (en) | 2019-10-01 |
| KR20140129124A (ko) | 2014-11-06 |
| IN2014MN01513A (enExample) | 2015-09-11 |
| EP2812026A4 (en) | 2016-04-27 |
| WO2013119863A1 (en) | 2013-08-15 |
| US20150023992A1 (en) | 2015-01-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112014019504A2 (pt) | alérgenos da erva-dos-prados e métodos e usos para modulação de resposta imune | |
| BR112014026072A2 (pt) | método para medir atenção | |
| BR112013007314A2 (pt) | anticorpos anti-cd48 e seus usos | |
| BR112014027571A2 (pt) | métodos para o tratamento de retinopatia diabética e outras doenças oftalmológicas | |
| BR112015010477A2 (pt) | combinação farmacêutica que compreende um inibidor b-raf e um inibidor de histona desacetilase e o uso dos mesmos no tratamento de doenças proliferativas | |
| BR112015003590A8 (pt) | Métodos para tratamento ou prevenção da asma por administração de um antagonista de il-4r | |
| BR112017009807A2 (pt) | métodos e formulações para tratamento de doenças oculares vasculares | |
| BR112015000150A2 (pt) | composições farmacêuticas dissuasoras de abuso de liberação controlada | |
| BR112016022499A2 (pt) | Produtos terapêuticos combinatórios supramoleculares | |
| UY35195A (es) | Composiciones y metodos para proteinas de accion prolongada | |
| BR112012027055A2 (pt) | agente estabilizante para proteínas farmacêuticas. | |
| BR112015005772A2 (pt) | método para a intensificação de imunoterapias específicas no tratamento de câncer | |
| BR112015006656A8 (pt) | composições e métodos para o tratamento de insuficiência cardíaca em pacientes diabéticos | |
| BR112016010166A2 (pt) | métodos para usar interleucina-10 para tratar doenças e distúrbios | |
| BR112014031327A2 (pt) | ácidos nucleicos para o tratamento de alergias | |
| BR112014023800A2 (pt) | moléculas de ácidos nucleicos artificiais | |
| BR112015017775A2 (pt) | enzima cistationina beta-sintase para o tratamento de homocistinúria | |
| BR112014012808A2 (pt) | proteína de fusão anticâncer | |
| BR112015011171A2 (pt) | compostos de pirrolopirimidina como inibidores da quinase | |
| BR112015000776A2 (pt) | Agentes de ligação à rspo3 e usos dos mesmos | |
| BR112014032699A2 (pt) | métodos de tratamento de síndrome metabólica pediátrica | |
| BR112015005117A2 (pt) | métodos de tratamento da doença de alzheimer e suas composições farmacêuticas | |
| BR112015001847A2 (pt) | composições e tratamento para doenças e distúrbios nos olhos | |
| WO2014204816A3 (en) | Method for assessing protein identity and stability | |
| BR112012030337A2 (pt) | vacinas compreendendo colesterol e cpg como moléculas veículo-adjuvante exclusivas e uso das mesmas |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 6A ANUIDADE. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2500 DE 04-12-2018 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |